CHD Surgical Team Exceeds National Average Outcomes for Pediatric and Adult Patients
Congenital heart disease (CHD) is the most common birth defect in the U.S. Due to medical breakthroughs and progress in treatment, there is a large population of adults with congenital heart disease. Currently, there are more than one million adults in the United States living with this disease, and this number continues to rise each year.
UMMC Congenital Heart Disease Surgical Outcome Data (July 1, 2013 – June 30, 2017)
Overall, adult congenital heart disease patients who receive surgery at University of Maryland Medical Center have significantly better outcomes than those treated at other hospitals nationwide, according to the Society of Thoracic Surgery (STS). Pediatric congenital heart disease patients at University of Maryland Medical Center also fare better when compared to other hospitals nationwide, according to the STS.
Treatment
The University of Maryland Medical Center multidisciplinary team of adult and pediatric cardiologists, cardiac surgeons, electrophysiologists, and other specialists provide personalized care for adults and children with any type of congenital heart problem. Our team of experts, including two of the nation's board-certified cardiologists in Adult Congenital Heart Disease, will guide your patients through disease management, emphasizing continuity of care and long-term follow up.
The University of Maryland CHD Program offers a comprehensive, multidisciplinary approach with:
- A full spectrum of care for patients from prenatal and birth to childhood and adulthood, all in one hospital that provides seamless lifetime care
- A dedicated team that includes: interventional cardiology, electrophysiology, anesthesia, radiology, perinatology, cardiac surgery, genetics, fetal medicine and cardiovascular medicine
- Expertise in complex procedures (full range of interventional procedures), ECMO (extracorporeal membrane oxygenation), eCPR (rapid deployment ECMO), percutaneous pulmonary valve replacement and heart transplantation
- A designated cardiac intensive care unit with 24-7 coverage by skilled nurses, nurse practitioners and intensivists
- One of the world's only stem cell programs for congenital heart disease patients, conducting cutting-edge clinical trials for hypoplastic left heart syndrome and dilated cardiomyopathy
- Surgical outcomes that exceed national standards (see charts)
Learn more about the high-performing Congenital Heart Disease Program at the University of Maryland Heart and Vascular Center.
Please call 410-328-7877 (adult) or 410-328-4348 (pediatrics) or visit Referring Physicians to make a referral.